☆ 4.3 Review

Digital technologies: Innovations that transform the face of drug development

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Related references

Note: Only part of the references are listed.

Review Medicine, Research & Experimental

Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital heath technologies

Elena S. Izmailova et al.

Summary: The FDA recognizes the importance of improving drug development efficiency and considers translational biomarkers to be a top priority. The use of imaging biomarkers has been associated with increased rates of drug approvals. Standardization and data sharing are key to the successful deployment of imaging biomarkers and can also accelerate the adoption of digital health technologies (DHTs) in developing novel treatments. Pre-competitive consortia and data standardization will advance the regulatory maturity of DHTs in clinical trials.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Add to Collection

Article Neurosciences

Clinical Trial Highlights - an update on previously reviewed trials

Kevin McFarthing et al.

JOURNAL OF PARKINSONS DISEASE (2022)

Add to Collection

Editorial Material Health Care Sciences & Services

Digital biomarkers: Convergence of digital health technologies and biomarkers

Srikanth Vasudevan et al.

Summary: The increasing digitization in healthcare has led to the development and adoption of Digital Health Technologies (DHT). The term 'digital biomarker' has been used to describe various measurements, and this study aims to align its meaning with established biomarker terminology and improve the assessment of scientific evidence for future digital biomarkers.

NPJ DIGITAL MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson's disease

Florian Lipsmeier et al.

Summary: Digital health technologies have the potential to provide reliable and valid estimates of motor sign severity and progression in Parkinson's disease. The Roche PD Mobile Application v2 demonstrated good reliability and validity in measuring motor sign severity in early-stage PD participants.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Chemistry, Analytical

Sensor Verification and Analytical Validation of Algorithms to Measure Gait and Balance and Pronation/Supination in Healthy Volunteers

Robert Ellis et al.

Summary: This study aimed to verify the technical and analytical validity of Apple iPhone and ActiGraph GT9X accelerometers for measuring motor function in Parkinson's disease. The results suggest that these accelerometers are suitable for assessing the motor function of patients.

SENSORS (2022)

Add to Collection

Review Medicine, Research & Experimental

Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience

Alan Godfrey et al.

Summary: Biometric monitoring technologies (BioMeTs) and laboratory biomarkers share common features but also have unique characteristics that require bench and human experimentation testing phases. Digitally measured biomarkers require prospective data collection for analytical validation and lack widely accepted performance characteristics, necessitating standardized evaluation methods.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Add to Collection

Review Geriatrics & Gerontology

Multimodal biometric monitoring technologies drive the development of clinical assessments in the home environment

Benjamin Vandendriessche et al.

Summary: Biometric monitoring technologies have drawn attention in healthcare for their user-friendly design and multi-sensor data collection capabilities. The use of multimodal BioMeTs can enhance digital measures, with identified unmet clinical needs and practical recommendations for adoption. The evolution towards at-home data collection focuses on prevention, personalization, and long-term outcomes, empowering healthcare providers and improving patient care standards.

MATURITAS (2021)

Add to Collection

Article Chemistry, Analytical

Toward a Regulatory Qualification of Real-World Mobility Performance Biomarkers in Parkinson's Patients Using Digital Mobility Outcomes

Marco Viceconti et al.

SENSORS (2020)

Add to Collection

Article Health Care Sciences & Services

Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)

Jennifer C. Goldsack et al.

NPJ DIGITAL MEDICINE (2020)

Add to Collection

Article Mathematical & Computational Biology

Estimation of clinical trial success rates and related parameters

Chi Heem Wong et al.

BIOSTATISTICS (2019)

Add to Collection

Article Medicine, Research & Experimental

Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine

Elena S. Izmailova et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)

Add to Collection

Article Medicine, Research & Experimental

Evaluation of Wearable Digital Devices in a Phase I Clinical Trial

Elena S. Izmailova et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)

Add to Collection

Review Clinical Neurology

Normal and pathological gait: what we learn from Parkinson's disease

David Grabli et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

Add to Collection

News Item Pharmacology & Pharmacy

The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development

C. D. Lathia et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

Add to Collection

Review Clinical Neurology

The role of actigraphy in sleep medicine

A Sadeh et al.

SLEEP MEDICINE REVIEWS (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.